Clinical trial

Safety and Efficacy Study of JV-GL1 in Patients With Open-Angle Glaucoma or Ocular Hypertension

NCT04761705

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention JV-GL1 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Latanoprost 0.005% Ophthalmic Solution Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Safety and Efficacy Study of JV-GL1 in Patients With Open-Angle Glaucoma or Ocular Hypertension

Design: INTERVENTIONAL · Status: SUSPENDED · Phase: PHASE1, PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusSUSPENDED

Study typeINTERVENTIONAL

Start date2021-03-10

PhasePHASE1 / PHASE2

Conditions

Ocular Hypertensionverified · MONDO: ocular hypertension

Open Angle Glaucomaverified · MONDO: open-angle glaucoma

Interventions

JV-GL1DRUG

Latanoprost 0.005% Ophthalmic SolutionDRUG

Sponsors & collaborators

JeniVision, Inc.lead sponsor

Mapped research locations

Newport BeachCalifornia, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04761705 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.